Albert Tuldrà

Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy

Albert Tuldrà, Carmina R. Fumaz, Ma José Ferrer et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2000 · 248 citations

Public Health, Pharmacotherapy, Hiv Control +16

Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Eugènia Negredo, Luís A. B. Cruz, Roger Paredes et al. · Clinical Infectious Diseases · 2002 · 170 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Quality of Life, Emotional Status, and Adherence of HIV-1–Infected Patients Treated With Efavirenz Versus Protease Inhibitor–Containing Regimens

Carmina R. Fumaz, Albert Tuldrà, Ma José Ferrer et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 148 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessing Self-Reported Adherence to HIV Therapy by Questionnaire: The SERAD (Self-Reported Adherence) Study

José A. Muñoz-Moreno, Carmina R. Fumaz, María José Ferrer et al. · AIDS Research and Human Retroviruses · 2007 · 58 citations · Full text

Public Health, Infectious Disease Control, Hiv Control +16

High-Dose Saquinavir Plus Ritonavir: Long-Term Efficacy in HIV-Positive Protease Inhibitor–Experienced Patients and Predictors of Virologic Response

Roger Paredes, Teresa Puig, Eugènia Negredo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 1999 · 23 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17